161 related articles for article (PubMed ID: 6208038)
1. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
Plata F; Wietzerbin J; Pons FG; Falcoff E; Eisen H
Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
[TBL] [Abstract][Full Text] [Related]
2. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
3. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
4. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
5. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction.
Rottenberg ME; Castaños-Velez E; de Mesquita R; Laguardia OG; Biberfeld P; Orn A
Eur J Immunol; 1996 Dec; 26(12):3203-13. PubMed ID: 8977323
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi affects nitric oxide production by murine peritoneal macrophages.
Pakianathan DR; Kuhn RE
J Parasitol; 1994 Jun; 80(3):432-7. PubMed ID: 8195945
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
8. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
11. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
12. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.
Torrico F; Heremans H; Rivera MT; Van Marck E; Billiau A; Carlier Y
J Immunol; 1991 May; 146(10):3626-32. PubMed ID: 1902858
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma.
Revelli S; Didoli G; Roggero E; Moreno H; Bernabo J; Wietzerbin J; Bottasso O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):153-9. PubMed ID: 9825840
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
[TBL] [Abstract][Full Text] [Related]
16. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
17. IL-10 mediates susceptibility to Trypanosoma cruzi infection.
Reed SG; Brownell CE; Russo DM; Silva JS; Grabstein KH; Morrissey PJ
J Immunol; 1994 Oct; 153(7):3135-40. PubMed ID: 8089491
[TBL] [Abstract][Full Text] [Related]
18. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: exposure of murine cells to live parasites in vitro leads to enhanced surface class I MHC expression which is type I interferon-dependent.
Stryker GA; Nickell SP
Exp Parasitol; 1995 Dec; 81(4):564-73. PubMed ID: 8542998
[TBL] [Abstract][Full Text] [Related]
20. Parasite specific antibodies in three strains of mice after infection with Trypanosoma cruzi.
Zweerink HJ; Anderson OF; Greenblatt HC; Murray PK
J Parasitol; 1985 Feb; 71(1):43-9. PubMed ID: 3920376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
